Oral bacterial metabolic enzymes and membranes

Oral bacterial metabolic enzymes and membranes represent a collective group of therapeutic targets within the oral microbiome, primarily associated with odontopathogenic bacteria like Streptococcus mutans and Porphyromonas gingivalis (Marsh, 2010). These targets include enzymes involved in carbohydrate metabolism and extracellular polysaccharide synthesis, such as glucosyltransferases (GTFs), as well as the structural integrity of the bacterial cell membrane (Bowen & Koo, 2011). In the context of dental health, pharmacological intervention aims to disrupt these systems to prevent the formation of dental plaque (biofilm) and the subsequent production of organic acids that lead to enamel demineralization (Takahashi & Nyvad, 2011). Common agents like chlorhexidine and cetylpyridinium chloride act by destabilizing bacterial membranes, leading to the leakage of intracellular components (James et al., 2017). Fluoride ions can inhibit intracellular enzymes like enolase, thereby reducing the rate of bacterial glycolysis and acid production (Marquis et al., 2003). Targeting these components is essential for the management of dental caries, gingivitis, and periodontal disease, though challenges include maintaining a healthy microbial balance and avoiding local side effects like staining or irritation.

Other names

Oral microbiome targetsDental plaque bacterial componentsOral biofilm enzymes and cell walls

Antimicrobial agents target these components through membrane disruption, leading to cytoplasmic leakage, and the inhibition of key metabolic enzymes such as glucosyltransferases and enolase, which reduces acid production and biofilm matrix synthesis (James et al., 2017; Marquis et al., 2003).